| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Biophysical Journal 71: 2094-2105 (1996)
© 1996 the Biophysical Society
Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
ABSTRACT
Hemoglobin tetramers [Zn/FeO(2)] containing oxygenated subunits (FeO(2)), in combination with unligated subunits containing zinc-substituted hemes (Zn), were analyzed to determine their contributions to the cooperativity of oxygen binding at the Fe sites. Energetic consequences of possible perturbation by zinc substitution were evaluated in all combinations of unligated Zn/Fe hybrid tetramers. A general thermodynamic strategy that corrects for the energetic effects of substituting a second metal for Fe showed the perturbations of Zn substitution to be negligible. This permitted cooperativity parameters of the native Fe/FeO(2) intermediates to be calculated from data on the corresponding Zn/FeO(2) molecules. These parameters, determined explicitly for all eight oxygen-binding intermediates (Fe/FeO(2)), were found to be identical to those predicted earlier from analyzing the O(2) binding data of normal hemoglobin according to the "molecular code" of hemoglobin allostery. The cooperativity parameters determined for this system showed the same distribution pattern found previously for five other oxygen analog systems (Fe/FeCN, FE/Mn(3+), Co/FECO, Co/FeCN, and Fe/FeCO).
This article has been cited by other articles:
![]() |
G. Schay, L. Smeller, A. Tsuneshige, T. Yonetani, and J. Fidy Allosteric Effectors Influence the Tetramer Stability of Both R- and T-states of Hemoglobin A J. Biol. Chem., September 8, 2006; 281(36): 25972 - 25983. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-M. Yun, H. Morimoto, and N. Shibayama The Contribution of the Asymmetric alpha 1beta 1 Half-oxygenated Intermediate to Human Hemoglobin Cooperativity J. Biol. Chem., January 11, 2002; 277(3): 1878 - 1883. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |